Transfusion and Apheresis Science
Volume 42, Issue 3 , Pages 247-251 , June 2010

Plasma exchange for treating cryoglobulinemia: A descriptive analysis

Received 12 January 2009 ,Revised 6 March 2009 ,Accepted 9 March 2009.

References 

  1. Siami FA, Siami GA. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases. Ther Apher. 1997;1(1):58–62
  2. Scarpato S, Tirri E, Naclerio C, Moscato P, Salvati G. Plasmapheresis in cryoglobulinemic neuropathy: a clinical study. Dig Liver Dis. 2007;39(Suppl. 1):S136–S137
  3. Cohen P, Nguyen QT, Dény P, Ferrière F, Roulot D, Lortholary O, et al. Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients. Ann Med Interne (Paris). 1996;147(2):81–86
  4. Russo GE, Caramiello MS, Vitaliano E, De Marco CM, Pennacchia M, Giusti S, et al. Haemorheological changes in mixed cryoglobulinaemia during apheresis treatment. Transfus Sci. 1996;17(4):499–503
  5. Frankel AH, Singer DR, Winearls CG, Evans DJ, Rees AJ, Pusey CD. Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients. Q J Med. 1992;82(298):101–124
  6. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2002;46(12):3317–3326
  7. Frohnert PP, Shepes SG. Long-term followup study of periateritis nodosa. Am J Med. 1967;43:8–14
  8. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg–Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44:666–675
  9. Vitti MP, Torriani A, Fugazza M, Fornasari PM, Stanziale D. The role of plasmapheresis in the treatment of primary and secondary cryoglobulinemia. Minerva Med. 1985;76(16):793–796
  10. Schena FP, Manno C, Dimonte D, Carabellese S, Cazzato L, Paglionico N, et al. Plasma-exchange in the treatment of cryoglobulinemia. Ric Clin Lab. 1983;13(1):133–140
  11. D’Amico G, Colasanti G, Ferrario F, Sinico RA. Renal involvement in essential mixed cryoglobulinemia. Kidney Int. 1989;35:1004
  12. Hausfater P, Cacoub P, Assogba U, Lebon P, Piette JC. Plasma exchange and interferon-alpha pharmacokinetics in patients with hepatitis C virus-associated systemic vasculitis. Nephron. 2002;91(4):627–630
  13. Casato M, Lagana B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood. 1991;78:3142–3147
  14. Ferri C, Marzo M, Longombardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood. 1993;81:1132–1136
  15. Misiani R, Bellavita P, Felini D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994;330:751–756
  16. Auzerie V, Chiali A, Bussel A, Brouet JC, Fermand JP, Dubertret L, et al. Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment. Arch Dermatol. 2003;139(3):391–393
  17. Siami GA, Siami FS. Cryofiltration apheresis in the United States. Ther Apher. 1998;2(3):228–235
  18. Siami GA, Wilkins W, Stone WJ, Koo AP, Zborowski M. Clinical trials of a cryoglobulin filter. ASAIO J. 1994;40(3):M658–M662
  19. Karmochkine M, Bussel A, Léon A, Jarrousse B, Baudelot J, Guillevin L. Long-term plasma exchange. Analysis of indications, outcome and side effects. Ann Med Interne (Paris). 1994;145(5):373–375
  20. Visco G, Giannuzzi R, Paglia MG, Visco Comandini U. Hemoperfusion and liver disease. Biomater Artif Cells Immobilization Biotechnol. 1993;21(2):265–281
  21. Siami FS, Siami GA. Plasmapheresis by using secondary membrane filters: a twelve-year experience. ASAIO J. 2000;46(4):383–388
  22. Ohshima T, Sawada K, Tanaka J, Zborowski M, Koo AP, Malchesky PS. Do humoral factors removed by plasmapheresis suppress the cellular immune system in cryoglobulinemia?. ASAIO Trans. 1991;37(3):M431–M433

PII: S1473-0502(10)00053-4

doi: 10.1016/j.transci.2010.03.001

Transfusion and Apheresis Science
Volume 42, Issue 3 , Pages 247-251 , June 2010

Article Tools

* Image Usage & Resolution